We also conducted a clinical sample test with PAAD samples, and the results of western blot and qRT-PCR analyses indicated that the expression of SNAI2 in the PAAD tissues was remarkably higher than that in normal tissues adjacent to cancer, which was also consistent with the database results. This evidence concerns the gene SNAI2 and pancreatic adenocarcinoma.